GTR was also associated with a clinically significant improvement of 21.8% in OS although this did not reach statistical significance (Five-year OS 81.3% vs 59.5.0%, P = .071, HR = 0.50) ( Table 2 ).
← all excerpts
SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort-A BIOMECA Consortium Study.
1
0.0710
0.0710